Apyx Medical Corporation (NASDAQ: APYX) Stock Competitors & Peer Comparison
See APYX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for APYX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| APYX | $4.05 | -2.64% | 170.5M | -18.41 | -$0.22 | N/A |
| ALC | $71.81 | +3.26% | 35B | 22.58 | $3.18 | +0.50% |
| STE | $237.47 | +2.45% | 23.2B | 22.80 | $10.42 | +1.06% |
| BRKRP | $400.35 | +2.91% | 8B | 217.58 | $1.84 | +0.38% |
| DRTSW | $3.40 | +4.13% | 1.3B | -5.26 | -$0.65 | N/A |
| SI | $20.59 | -8.20% | 427M | -10.75 | -$1.91 | N/A |
| MOBI | $12.24 | -0.65% | 407M | -0.65 | -$18.78 | N/A |
| MASS | $8.88 | +6.99% | 364.3M | -14.80 | -$0.60 | N/A |
| EDAP | $4.76 | -0.52% | 178.2M | -5.80 | -$0.82 | N/A |
| NYXH | $1.47 | +12.21% | 58.2M | -0.58 | -$2.52 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
APYX vs ALC Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, ALC has a market cap of 35B. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while ALC trades at $71.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas ALC's P/E ratio is 22.58. In terms of profitability, APYX's ROE is -0.79%, compared to ALC's ROE of +0.04%. Regarding short-term risk, APYX is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for APYX.Check ALC's competition here
STERIS plc (NYSE: STE)
APYX vs STE Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, STE has a market cap of 23.2B. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while STE trades at $237.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas STE's P/E ratio is 22.80. In terms of profitability, APYX's ROE is -0.79%, compared to STE's ROE of +0.11%. Regarding short-term risk, APYX is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for APYX.Check STE's competition here
Bruker Corporation (NASDAQ: BRKRP)
APYX vs BRKRP Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, BRKRP has a market cap of 8B. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while BRKRP trades at $400.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas BRKRP's P/E ratio is 217.58. In terms of profitability, APYX's ROE is -0.79%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, APYX is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for APYX.Check BRKRP's competition here
Alpha Tau Medical Ltd. (NASDAQ: DRTSW)
APYX vs DRTSW Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, DRTSW has a market cap of 1.3B. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while DRTSW trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas DRTSW's P/E ratio is -5.26. In terms of profitability, APYX's ROE is -0.79%, compared to DRTSW's ROE of -0.73%. Regarding short-term risk, APYX is more volatile compared to DRTSW. This indicates higher risk in terms of short-term price fluctuations for APYX.Check DRTSW's competition here
Shoulder Innovations, Inc. (NYSE: SI)
APYX vs SI Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, SI has a market cap of 427M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while SI trades at $20.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas SI's P/E ratio is -10.75. In terms of profitability, APYX's ROE is -0.79%, compared to SI's ROE of -0.24%. Regarding short-term risk, APYX is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for APYX.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
APYX vs MOBI Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, MOBI has a market cap of 407M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while MOBI trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas MOBI's P/E ratio is -0.65. In terms of profitability, APYX's ROE is -0.79%, compared to MOBI's ROE of +0.31%. Regarding short-term risk, APYX is more volatile compared to MOBI. This indicates higher risk in terms of short-term price fluctuations for APYX.Check MOBI's competition here
908 Devices Inc. (NASDAQ: MASS)
APYX vs MASS Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, MASS has a market cap of 364.3M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while MASS trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas MASS's P/E ratio is -14.80. In terms of profitability, APYX's ROE is -0.79%, compared to MASS's ROE of -0.26%. Regarding short-term risk, APYX is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for APYX.Check MASS's competition here
Edap Tms S.a. (NASDAQ: EDAP)
APYX vs EDAP Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas EDAP's P/E ratio is -5.80. In terms of profitability, APYX's ROE is -0.79%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, APYX is more volatile compared to EDAP. This indicates higher risk in terms of short-term price fluctuations for APYX.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
APYX vs NYXH Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, NYXH has a market cap of 58.2M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while NYXH trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas NYXH's P/E ratio is -0.58. In terms of profitability, APYX's ROE is -0.79%, compared to NYXH's ROE of -1.64%. Regarding short-term risk, APYX is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for APYX.Check NYXH's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
APYX vs MDAI Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, MDAI has a market cap of 55.7M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while MDAI trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas MDAI's P/E ratio is -3.89. In terms of profitability, APYX's ROE is -0.79%, compared to MDAI's ROE of +1.79%. Regarding short-term risk, APYX is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for APYX.Check MDAI's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
APYX vs WOK Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while WOK trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas WOK's P/E ratio is N/A. In terms of profitability, APYX's ROE is -0.79%, compared to WOK's ROE of -0.07%. Regarding short-term risk, APYX is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for APYX.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
APYX vs QTEXW Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, APYX's ROE is -0.79%, compared to QTEXW's ROE of N/A. Regarding short-term risk, APYX is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for APYX.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
APYX vs ITOC Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, ITOC has a market cap of 2.7M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while ITOC trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas ITOC's P/E ratio is -0.93. In terms of profitability, APYX's ROE is -0.79%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, APYX is more volatile compared to ITOC. This indicates higher risk in terms of short-term price fluctuations for APYX.Check ITOC's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
APYX vs BIAFW Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, BIAFW has a market cap of 2.5M. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while BIAFW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas BIAFW's P/E ratio is 0.27. In terms of profitability, APYX's ROE is -0.79%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, APYX is more volatile compared to BIAFW. This indicates higher risk in terms of short-term price fluctuations for APYX.Check BIAFW's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
APYX vs FEED Comparison August 2026
Apyx Medical Corporation (NASDAQ: APYX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APYX stands at 170.5M. In comparison, FEED has a market cap of 434.6K. Regarding current trading prices, APYX is priced at $4.05 on the NASDAQ, while FEED trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APYX currently has a P/E ratio of -18.41, whereas FEED's P/E ratio is -0.01. In terms of profitability, APYX's ROE is -0.79%, compared to FEED's ROE of -0.44%. Regarding short-term risk, APYX is more volatile compared to FEED. This indicates higher risk in terms of short-term price fluctuations for APYX.Check FEED's competition here